• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Respiratory syncytial virus with ongoing COVID-19: is it an emerging threat?

作者信息

Sah Ranjit, Zaman Kamran, Mohanty Aroop, Al-Ahdal Tareq, Awad Hamzeh, Padhi Bijay Kumar, Bhargava Ashish

机构信息

Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal.

D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra.

出版信息

Ann Med Surg (Lond). 2023 Jan 18;85(1):67-70. doi: 10.1097/MS9.0000000000000153. eCollection 2023 Jan.

DOI:10.1097/MS9.0000000000000153
PMID:36742116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9893426/
Abstract
摘要

相似文献

1
Respiratory syncytial virus with ongoing COVID-19: is it an emerging threat?呼吸道合胞病毒与持续的新冠病毒感染：它是一种新出现的威胁吗？
Ann Med Surg (Lond). 2023 Jan 18;85(1):67-70. doi: 10.1097/MS9.0000000000000153. eCollection 2023 Jan.
2
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.呼吸道合胞病毒，一个持续存在的医学难题：关于目前正在进行临床试验的呼吸道合胞病毒预防和治疗药物的专家评论
Influenza Other Respir Viruses. 2015 Jul;9(4):169-78. doi: 10.1111/irv.12313.
3
Respiratory Syncytial Virus Pediatric Hospitalization in the COVID-19 Era.COVID-19 时代的呼吸道合胞病毒儿童住院治疗。
Int J Environ Res Public Health. 2022 Nov 22;19(23):15455. doi: 10.3390/ijerph192315455.
4
Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children.儿童严重急性呼吸综合征冠状病毒2与呼吸道合胞病毒合并感染
Osong Public Health Res Perspect. 2021 Oct;12(5):286-292. doi: 10.24171/j.phrp.2021.0140. Epub 2021 Oct 1.
5
Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020.2020 年 1 月至 10 月，南非 COVID-19 大流行期间基于机构的监测中流感和呼吸道合胞病毒检测的下降。
Euro Surveill. 2021 Jul;26(29). doi: 10.2807/1560-7917.ES.2021.26.29.2001600.
6
Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic.COVID-19 大流行期间呼吸道合胞病毒季节性变化。
Infection. 2022 Aug;50(4):1001-1005. doi: 10.1007/s15010-022-01794-y. Epub 2022 Mar 22.
7
Waning Immunity Against Respiratory Syncytial Virus During the Coronavirus Disease 2019 Pandemic.2019 冠状病毒病大流行期间呼吸道合胞病毒免疫力下降。
J Infect Dis. 2022 Dec 13;226(12):2064-2068. doi: 10.1093/infdis/jiac192.
8
Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan.日本东京新冠疫情后预计将爆发呼吸道合胞病毒疫情。
Jpn J Infect Dis. 2022 Mar 24;75(2):209-211. doi: 10.7883/yoken.JJID.2021.312. Epub 2021 Aug 31.
9
Respiratory Syncytial Virus Infections in Young Children Presenting to Primary Care in Catalonia During the COVID-19 Pandemic.儿童呼吸道合胞病毒感染在 COVID-19 大流行期间在加泰罗尼亚向初级保健就诊。
J Pediatric Infect Dis Soc. 2022 Feb 23;11(2):69-72. doi: 10.1093/jpids/piab121.
10
Human parainfluenza 3 and respiratory syncytial viruses detected in pangolins.在穿山甲中检测到人类副流感 3 型和呼吸道合胞病毒。
Emerg Microbes Infect. 2022 Dec;11(1):1657-1663. doi: 10.1080/22221751.2022.2086071.

引用本文的文献

1
Optimizing risk factors to guide COST-effective use of palivizumab in KOREAN infants.优化风险因素以指导韩国婴儿高效使用帕利珠单抗。
Pediatr Int. 2025 Jan-Dec;67(1):e70021. doi: 10.1111/ped.70021.
2
Predictors of prolonged length of stay in adult patients with respiratory syncytial virus infections - a multi-center historical cohort study.成人呼吸道合胞病毒感染患者住院时间延长的预测因素——一项多中心历史性队列研究。
Front Microbiol. 2024 Apr 4;15:1385439. doi: 10.3389/fmicb.2024.1385439. eCollection 2024.
3
Prevalence of Upper Respiratory Tract Infections Before, During, and After the COVID-19 Pandemic in Germany: A Cross-Sectional Study of 2 167 453 Outpatients.德国 COVID-19 大流行前后上呼吸道感染的患病率：2167453 名门诊患者的横断面研究。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231204436. doi: 10.1177/21501319231204436.
4
Factors associated with mild bronchiolitis in young infants.与小婴儿轻度细支气管炎相关的因素。
J Am Coll Emerg Physicians Open. 2023 May 16;4(3):e12966. doi: 10.1002/emp2.12966. eCollection 2023 Jun.

本文引用的文献

1
Respiratory Syncytial Virus (RSV) Update.呼吸道合胞病毒（RSV）更新。
Viruses. 2022 Sep 23;14(10):2110. doi: 10.3390/v14102110.
2
Determinants of RSV epidemiology following suppression through pandemic contact restrictions.大流行接触限制抑制 RSV 流行后的流行病学决定因素。
Epidemics. 2022 Sep;40:100614. doi: 10.1016/j.epidem.2022.100614. Epub 2022 Jul 21.
3
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis.美国成年人中接受医疗护理的呼吸道合胞病毒感染率：一项系统评价与荟萃分析。
Open Forum Infect Dis. 2022 Jun 17;9(7):ofac300. doi: 10.1093/ofid/ofac300. eCollection 2022 Jul.
4
Factors Associated With Severe Illness in Patients Aged <21 Years Hospitalized for COVID-19.与 COVID-19 住院的<21 岁患者重症相关的因素。
Hosp Pediatr. 2022 Sep 1;12(9):760-783. doi: 10.1542/hpeds.2022-006613.
5
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计：系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
6
Hospitalized Children With Common Human Coronavirus Clinical Impact of Codetected Respiratory Syncytial Virus and Rhinovirus.住院儿童常见人类冠状病毒与呼吸道合胞病毒和鼻病毒共检出的临床影响。
Pediatr Infect Dis J. 2022 Mar 1;41(3):e95-e101. doi: 10.1097/INF.0000000000003433.
7
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US.美国 COVID-19 大流行后呼吸道合胞病毒再出现的时间和强度估计。
JAMA Netw Open. 2021 Dec 1;4(12):e2141779. doi: 10.1001/jamanetworkopen.2021.41779.
8
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.帕利珠单抗预防儿童严重呼吸道合胞病毒（RSV）感染。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013757. doi: 10.1002/14651858.CD013757.pub2.
9
Respiratory syncytial virus: paying the immunity debt with interest.呼吸道合胞病毒：加倍偿还免疫债。
Lancet Child Adolesc Health. 2021 Dec;5(12):e44-e45. doi: 10.1016/S2352-4642(21)00333-3. Epub 2021 Oct 23.
10
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森（强生）疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.